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Bioelectric-calcineurin signaling 
module regulates allometric growth 
and size of the zebrafish fin
Jacob M. Daane1, Jennifer Lanni1,2, Ina Rothenberg3, Guiscard Seebohm3, Charles W. Higdon4, 
Stephen L. Johnson4 & Matthew P. Harris1
The establishment of relative size of organs and structures is paramount for attaining final form and 
function of an organism. Importantly, variation in the proportions of structures frequently underlies 
adaptive change in morphology in evolution and maybe a common mechanism underlying selection. 
However, the mechanism by which growth is integrated within tissues during development to achieve 
proper proportionality is poorly understood. We have shown that signaling by potassium channels 
mediates coordinated size regulation in zebrafish fins. Recently, calcineurin inhibitors were shown to 
elicit changes in zebrafish fin allometry as well. Here, we identify the potassium channel kcnk5b as a 
key player in integrating calcineurin’s growth effects, in part through regulation of the cytoplasmic 
C-terminus of the channel. We propose that the interaction between Kcnk5b and calcineurin acts as 
a signaling node to regulate allometric growth. Importantly, we find that this regulation is epistatic 
to inherent mechanisms instructing overall size as inhibition of calcineurin is able to bypass genetic 
instruction of size as seen in sof and wild-type fins, however, it is not sufficient to re-specify positional 
memory of size of the fin. These findings integrate classic signaling mediators such as calcineurin with 
ion channel function in the regulation of size and proportion during growth.
The establishment of relative proportion of structures and organs is essential for the normal physiology and 
function of an organism. The study of differential growth of structures in development and in the evolution 
of form has a rich history1. A key advance in our understanding differential growth stems from the work of 
D’Arcy Thompson and his efforts to define the underlying rules of coordinated transformations in form2. This 
foundational work was leveraged by Huxley and Teissier who formalized scaling relationships between struc-
tures within organisms as a power law that details the relative proportion of structures3,4. This law provides a 
scale-independent means of comparing growth in development and among species.
A common mechanism for the establishment of organ size and the relative proportions of structures is 
through differential sensitivity of organs to a systemic growth signal such as insulin-like growth factors (IGF) 
or growth hormone (GH)5,6. However, there is substantial evidence for an organ-intrinsic capacity to establish 
relative size that is robust to such broad systemic signals. Transplanted organs will frequently reach their tar-
get size even when cultured in ectopic locations7–9. Intrinsic regulation of size in structures is also observed 
in cases in which organs will accelerate growth back to a seemingly pre-ordained growth trajectory following 
growth-limiting insults, such as nutrient deprivation or illness10,11. This “catch-up growth” is also seen during 
epimorphic regeneration, wherein growth rate is dependent on the amount of tissue lost such that recovery of the 
original form occurs within the same time window; this suggests that relative growth rates are guided by retained 
positional cues within tissues12–15. How growth is integrated with positional information within the organ to 
achieve proper proportion remains unclear.
An effective strategy to understand growth and regulation of size is to analyze mutants or experimental con-
ditions in which scaling properties have been altered. Through genetic screens in the zebrafish, several mutants 
have been identified that have adult fins that are reduced in size as well as mutants in which fins grow beyond their 
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normal limit16–23. The another longfin mutant was identified as having enlarged fins and barbels24. We have pre-
viously shown that alf is caused by a specific gain-of-function point mutation in the potassium channel kcnk5b, a 
member of the TWIK/TASK two pore family (K2P) of potassium channels20. Supporting a role for ion regulation 
in establishing proportion, the shortfin (sof) mutant has been mapped back to mutations in the gap junction con-
nexin43 (cx43/gja1)18,25. Though both gap junctions and potassium channels have important roles in physiology 
and cell biology, these initial findings in the zebrafish fin are surprising in that they uncover a specific role for 
local bioelectric signaling in the regulation and coordination of growth.
Insight into the mechanisms regulating coordinated growth also comes from pharmacological regulation of 
cell signaling during development. Inhibition of calcineurin in developing and regenerating fins by FK506 and 
cyclosporin A specifically increases the size of the resulting fin26. Calcineurin is a protein phosphatase known to 
affect transcription through direct binding and dephosphorylation of the NFAT family of transcription factors27. 
Analysis of the patterning and gene expression profiles in overgrown fins treated with FK506 led Kujawski and 
colleagues to suggest that positional information of the fin was specifically altered by calcineurin inhibition. 
Under this hypothesis, activation of calcineurin triggers a proximal-like growth program that leads to enhanced 
proliferation to re-specify larger fin sizes26.
Here, we extend analysis into mechanisms of size regulation by potassium channels and calcineurin using 
the zebrafish fin as a model. We show that FK506 can mirror the growth effects of activated Kcnk5b, and can 
override genetic determination of size. Importantly, we demonstrate that Kcnk5b function is a key component to 
the ability of FK506 to regulate growth. Through our genetic and experimental analyses, we demonstrate that the 
growth-mediating properties of FK506 do not re-specify positional memory in the fin, but rather act to maintain 
heightened rate of growth during regeneration of the fin. These data advance our understanding of how size is 
regulated during growth and provide a regulatory link between bioelectric and classical signaling pathways in the 
regulation of growth and proportion.
Results
Skeletal phenotypes of fins treated with FK506 compared to mutants affecting fin proportion. 
Fins are composed of multiple segmented rays of dermal bone. Elongation of the fin occurs through sequential 
addition of these bony segments to the distal fin tip. The zebrafish fin-ray segments are regularly patterned such 
that each segment is of roughly same length along the proximal-distal axis. While the segmentation pattern of the 
fin rays can be dissociated from total fin length28, mutants with altered fin size are often accompanied by a change 
in size of segments, consistent with alterations in the rate of growth17,20,25. The fin segments in kcnk5b/alf mutant 
are generally elongated, while those of the shortfin mutant are shorter18,20 (Fig. S1).
As segmentation patterns are influenced by mutations that alter fin size, we asked whether FK506 treatment 
had an effect on segmentation patterning. We focused primarily on fin regeneration, which recapitulates growth 
properties that occur during fin development. During fin regeneration, both the missing fin tissue and segmenta-
tion patterns are precisely restored. Thus, regeneration assays can serve as a foundation for exploring the genetic 
contributions of positional identity and memory, growth rate, and patterning. Treatment of regenerating fins 
with the calcineurin inhibitors FK506 and cyclosporin A led to dose-dependent coordinated overgrowth of fin 
regenerates (Fig. S1E)26. FK506-treated fins also exhibited elongated fin ray segments, similar to those observed 
in kcnk5b/alf mutants (Fig. S1E–G). Surprisingly, FK506 treatment of cx43/shortfin regenerating fins also resulted 
in elongated fin ray segments (Fig. S1H).
FK506 treatment regulates growth independently of memory of size. As treatment of fins with 
FK506 appears to bypass the genetic specification of normal fin length in wild-type fish26, we sought to define 
the growth characteristics of inhibiting calcineurin in the background of different mutants with altered fin size. 
Similar to wildtype, when cut to 50% of their initial size, the fins of short-finned (cnx43/sof) and long-finned 
(kcnk5b/alf) fish regenerate back to their pre-amputation size over a similar time period despite their vastly dif-
ferent starting lengths (Fig. 1). However, FK506-treatment of regenerating fins from both wild-type and cnx43 
short-finned mutants leads to an increased rate of growth in each group, resulting in the formation of simi-
larly sized, larger fins in both genotypes (Fig. 1). Oddly, the shape and size of FK506-treated fins from cx43/sof 
mutants were indistinguishable from treated wild-type fins (Fig. S1H). Of note, FK506-treatment of fish with 
gain-of-function of kcnk5b activity does not lead to an additional increase in the size of the regenerate or rate 
of its growth over untreated mutants (Fig. 1). All fins treated with FK506 regrow at comparably increased rates, 
regardless of genotype or previous size. These data suggest that the effect of calcineurin on fin growth is acting 
at, or downstream of, mechanisms specifying size. Further, the phenotypic similarities between alf and those of 
FK506-treated fins raise the potential that these two mechanisms may be integrated.
Kcnk5b activity is critical for growth effects of FK506. Fish deficient for kcnk5b have normal fin pro-
portions and growth20. To assess the role of Kcnk5b in calcineurin growth regulation, we resected the pecto-
ral fins of kcnk5b−/− fish and asked if the channel is needed for the FK506 growth response. Unexpectedly, the 
growth effects driven by FK506 treatment are suppressed in kcnk5b−/− fish (Fig. 2A–C). This effect was seen in 
both pectoral fin as well as caudal fin regeneration (Fig. 2D). These data reveal that Kcnk5b is a critical compo-
nent of FK506-mediated regulation of growth and size. Some additional growth occurs after FK506 treatment in 
kcnk5b−/− fish, raising the possibility that residual function of the kcnk5a paralogue or other targets of FK506 may 
contribute in part to the FK506 response.
Modification of kcnk5b function by calcineurin. Kcnk5b could mediate FK506 growth effect indi-
rectly or through modification of calcineurin regulation. Increasing the levels of wild-type kcnk5b locally in the 
fin is sufficient to induce fin overgrowth20. As large changes in transcription are observed in regenerating fins 
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treated with FK50626, we hypothesized that FK506 mediated overgrowth could be due to upregulation of kcnk5b 
expression levels. However, we find that expression of kcnk5b is not significantly altered in wild-type regenerating 
fins after FK506 treatment (Fig. 3A). To test the potential for direct modulation of channel activity by FK506/
calcineurin, we assessed the change in conductance of Kcnk5b channel variants in Xenopus oocytes. Oocytes 
expressing wild-type zebrafish Kcnk5b show decreased conductance when treated with FK506 (Fig. 3D,E; see 
Nam et al.29). Similarly, treatment of oocytes expressing kcnk5b with VIVIT, an independent peptide inhibitor 
of calcineurin, showed a comparable decrease in conductance, supporting a role of calcineurin in regulation of 
channel activity (Fig. 3E inset).
It has been shown that the activity of another KCNK two-pore potassium channel family member, Kcnk18/
TRESK, is regulated by direct binding of calcineurin to the intracellular loop of the channel. This binding affects 
downstream dephosphorylation events on conserved serine residues on the C-terminus of the channel30,31. 
Intriguingly, we identified a putative calcineurin binding site in the cytoplasmic C-terminus of zebrafish Kcnk5b 
that is similar to that identified in KCNK18/TRESK (Fig. 3B). Czirják et al. previously demonstrated that an iso-
leucine to alanine mutation in this domain in TRESK attenuated the effect of calcineurin and its binding to the 
channel30. We mutated the co-responding residue in the presumptive binding site in Kcnk5b (I290A; Fig. 3B) and 
assessed the effect on conductance of the channel in oocytes. Oocytes expressing Kcnk5b/I290A had lower con-
ductance than wildtype, but were similar to wild-type channels treated with FK506 (Fig. 3C–E). Importantly, the 
Kcnk5b/I290A expressing oocytes were also non-responsive to FK506 treatment. Thus, the effect of the altering 
the molecular characteristics of this site on the Kcnk5b C-terminal intracellular domain is comparable in effect to 
chemical inhibition of calcineurin by FK506. This result suggests that, similar to KCNK18, the activity of Kcnk5b 
is modulated by calcineurin through interactions with the cytoplasmic C-terminus.
The alf mutation affects the last transmembrane domain of the channel located just prior to the predicted 
calcineurin binding site (Perathoner et al.20, Fig. S3). In an effort to screen for further variants affecting growth 
within this region, we used CRISPR-targeted Cas9 genetic editing with guides targeted to the fifth exon of kcnk5b, 
which contains the transmembrane and C-terminus, and screened adults for somatic clones sufficient to cause 
Figure 1. Calcineurin inhibition is sufficient to override genetic encoding of size. (A) Regenerative growth 
of zebrafish pectoral fins after resection to ~50% of pre-cut fin length at 0 days post amputation in different 
genetic backgrounds with short- (cx43sof/sof) or long- (kcnk5balf) fin size relative to wild-type fish. Dashed lines 
indicate pre-cut pectoral fin length. Data normalized to standard length (STL) of each fish. ANOVA genotype 
by treatment interaction test F(2,23) = 27.89, p < 0.0001. Pairwise comparisons (ANOVA p-value): alf FK506-
alf DMSO (1.0), alf DMSO-sof FK506 (0.25), alf DMSO-wt FK506 (0.25), wt FK506-sof FK506 (1.0), sof FK506-
sof DMSO (<0.0001), wt FK506-wt DMSO (0.0013). (B) Representative ventral view of pectoral fins after 
regeneration. Black line indicates unoperated pectoral fin length. Red line indicates pectoral fin length after 
treatment with FK506 during regeneration. Black dashed line highlights site of amputation. Growth rate of 
FK506-treated regenerating caudal fins. (D) Caudal fins were resected to 50% of their original size and treated 
with FK506. Growth rate is analyzed through 9 days post amputation, when regenerative growth rate for DMSO 
treated fins begins to slow. Two-tailed t-test p < 0.0007 for suppression of growth in the absence of kcnk5b. Error 
bars represent ± SEM.
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overgrowth. We recovered fish having overgrowth caused by guides targeting the transmembrane region of the 
channel. Analysis of Kcnk5b in these clones revealed formation of frameshift mutations leading to early termi-
nation (Fig. S3). Thus, loss of the last transmembrane domain and the cytoplasmic tail of Kcnk5b is sufficient to 
lead to increased proportion.
Calcineurin signaling does not re-specify positional cues, rather overrides them. We have 
demonstrated an interaction between Kcnk5b and calcineurin-mediated signaling in regulating growth. However, 
the ability of this module to specify growth or identity of the fin remains unclear. Kujawski et al.26 provide 
evidence of perdurance of proximal markers in treated fins and suggest that calcineurin inhibition leads to a 
re-specification of the regenerating tissue to a proximal identity. However, these data are also consistent with 
the hypothesis that the treatment leads to a sustained increase in the rate of growth that then is associated with 
broader domains of regional markers in the enlarged regenerated tissue. To address the effect of calcineurin on 
altering positional information of the fin, we mirrored classic experiments of Maden (1982)32 in regulation of 
positional identity of limb regenerates in the salamander and asked if limited alteration of calcineurin could 
respecify identity of the fin regenerate and thus its interpretation of fate.
We first approached this question by addressing how fins respond when FK506 is removed. Pectoral fins 
regenerating under the influence of FK506 exhibited increased growth (Figs 2 and S1). However, after removal 
of the drug, either prior to achieving their original size, or in fins that had surpassed their original size, regen-
erative growth quickly stopped regardless of the extent of the fin regenerate (Fig. 4A). Thus, FK506 induces an 
acceleration of growth that requires continual presence of the drug for sustained overgrowth. We extended these 
studies to address if the identity of the regenerated tissue was altered by treatment with FK506. As amputated 
fins will regenerate back to a size similar to that originally specified during development, the fin tissue remaining 
after amputation retains information concerning size and proportion that is then integrated in the regenerate. 
However, if overgrown fins caused by FK506 inhibition of calcineurin are resected, either into the original fin 
tissue or within a regenerated portion of the fin, these resulting regenerates grew only to the original size of the 
Figure 2. Kcnk5b mediates the effect of calcineurin in regulating proportion. (A) Example of growth of 
pectoral fins of wildtype or kcnk5b deletion mutants regenerating after treatment with FK506. Dashed line 
indicates plane of section; black bar extent of growth of untreated fin; red, resected fin. (B) Growth rates of 
wildtype and kcnk5b deficient zebrafish. Dashed line, size of original pre-cut fin. Error bars represent ± SEM. 
ANOVA genotype by treatment interaction F(1,45) = 6.59, p = 0.014. Pairwise comparisons (ANOVA p-value): 
kcnk5b−/− FK506-wt FK506 (0.0013), kcnk5b−/− DMSO-wt DMSO (1.0), kcnk5b−/− FK506-kcnk5b−/− DMSO 
(0.022). (C) Growth rate of regenerating fins of different kcnk5b genotypes treated with FK506. Gray dots 
represent individual fish. Two-tailed t-test p < 0.0002 for suppression of growth in the absence of kcnk5b. Data 
is from four independent experiments. (C) Representative ventral view of pectoral fins after regeneration.
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Figure 3. FK506 effect on Kcnk5b activity is modulated by the cytoplasmic domain of the channel. (A) qRT-
PCR comparing relative levels of kcnk5b in FK506-treated, 5-day post-amputation pectoral fin blastemas 
to values of DMSO-treated controls (n = 5, ±SEM). (B) Multiple sequence alignment of Kcnk5b protein 
highlighting putative calcineurin binding domain with resemblance to calcineurin binding in TRESK 
(red bar, PQIVID30 and a nearby suite of highly conserved serine residues (green bars). Asterisk indicates 
site of mutagenesis in (C–E) (I290A). Alignment generated by MUSCLE55. Diagram adapted from56. (C) 
Representative electrophysiology current traces from voltage clamp recordings in Xenopus oocyte injected with 
wild-type or mutant I290A Kcnk5b cRNA and treated with FK506 or DMSO. The membrane potential was 
clamped at a reference potential of −80 mV and then varied by incremental 20 mV steps to a range of −100 mV 
to +60 mV. (D) Current is suppressed in wild-type Kcnk5b homodimers through treatment with FK506 or by 
mutation of the calcineurin binding site (I290A). (E) Recorded currents were normalized to the value recorded 
for oocytes injected with the wild-type channel at +60 mV. Inset, Xenopus oocytes expressing wild-type 
zebrafish Kcnk5b were injected with VIVIT peptide or carrier. Patch clamp experiments registered the resulting 
conductance. **p < 0.001, n, number of oocytes assessed.
Figure 4. Calcineurin inhibition establishes regenerative growth rate independently of positional identity. 
(A) Pulse of FK506 treatment for 6 or 14 days post-amputation to assess effects of transient inhibition of 
calcineurin by FK506 on growth and patterning of the fin. Fins were cut to 50% original length and allowed to 
regenerate in the presence of FK506. Arrows indicate end of drug treatment (n = 5 fish per treatment group). 
(B) Subsequent regeneration of the pectoral fins from (A) in the absence of FK506 after resection at original 
cut site to determine if fin allometry was re-set to a larger size through previous FK506 treatment. (C) Second 
regeneration of FK506-treated fins cut at a site within the regenerated tissue demonstrating memory of original 
positional information and recovery of wild-type size within the pectoral fin. Gray dashed line indicates pre-cut 
fin length. Red dashed lines indicate second resection. Error bars represent ± SEM.
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fin prior to treatment with FK506 (Fig. 4B,C). Similarly, FK506-treated overgrown fins cut beyond the original 
wild-type fin length failed to grow further upon amputation without the presence of the drug (Fig. 4C). Similar 
effects were seen in when tested in both pectoral as well as caudal fin regenerates (Fig. S2). Thus, Kcnk5b/cal-
cineurin signaling does not lead to lasting alterations in positional identity, but rather regulates rate of growth 
leading to enhanced fin proportions.
Discussion
Bioelectric integration of growth and form. Bioelectric potential is manifest as a resting voltage state of 
cells (Vmem). While it is clear that specialized cells such as nerves and cardiomyocytes have honed the regulation 
of electrical potential for specific functions, a broader role of this signaling in development and homeostasis is 
becoming apparent as it is necessary for normal pattern and growth of diverse organ systems33–37. Natural and 
experimental changes of resting potential can have broad effects in morphogenesis. A key property of bioelectric 
signaling is the capacity to coordinate responses across cells and tissues. Many tissues are electrically coupled 
through the action of gap junctions, and localized signals can expand via paracrine signaling by local fluctuations 
in electrical fields38. Thus, the integration of cellular- and tissue-level responses to inductive signals as well as 
integration of patterning cues within developing organs can be orchestrated though electrical coupling of cells 
such that a unified structure is formed and maintained. Perturbations of such electrically coupled-developmental 
systems could be a factor for the coordinated transformations observed in evolution2,39 and broad patterning 
phenotype observed in some diseases 37,40. The role of kcnk5b in regulation of proportion was identified in genetic 
screens through its actions in causing altered scaling properties of adult fins (Perathoner et al.20). We show that 
Kcnk5b is a key component to increased fin growth caused by calcineurin inhibition. Importantly, our work here 
demonstrates that Kcnk5b/calcineurin signaling is sufficient to increase growth regardless of innate size and gen-
otype and thus override, but not re-specify, positional identity of the fin.
We demonstrate that Knck5b, like Kcnk18, can signal through calcineurin via a region in its C-terminus. 
Altering the presumptive binding site on the C-terminus of Kcnk5b (I290A) is sufficient to mirror the effect of 
calcineurin inhibition and to remove sensitivity to FK506 treatment for conductance. FK506 treatment of Kcnk5b 
in oocytes leads to decreased current. Similarly, the I290A mutation also mirrors this response. In contrast, alf 
mutants20 show increased conductance in oocytes. This difference of the direction of conductance with similar 
growth outcomes may also point to the importance of signaling events downstream of changes in conductance 
that drive fin growth. The C-terminus of mouse Kcnk5/TASK-2 interacts directly with Gβγ subunit of heterotri-
meric G-proteins41, and work on other two pore potassium channels, such as TREK-1 and TREK-2, has revealed 
dynamic regulation by cAMP/PKA, DAG/PIP/PKC and nitric oxide/cGMP/PKG pathways42. Modulation of 
Kcnk5b activity by conductance, or through interactions with its C-terminus, may act to adjust and/or respond to 
changes in voltage to regulate growth rate. Interestingly, we have found that premature truncation mutations lead-
ing to channels that lack the last transmembrane domain and the C-terminus of Kcnk5b result in fin overgrowth 
comparable to that seen in the alf mutant, which affects the identical region (F241Y, Fig. S3). As null alleles of 
kcnk5b do not cause an overgrowth phenotype, the truncation mutation appears to cause an increase in function 
of the channel. Alteration of the pore structure or conformation/presence of the C-terminus may cause dysregu-
lated channel activity leading to overgrowth. The regulation of calcineurin may reflect downstream response to 
changes in conductance or conformation and thus, link calcium signaling to changes in pore conductance and/or 
conformation. In support of these findings, there is evidence that polarization-dependent differentiation of myo-
blasts requires calcineurin function in a manner that is sensitive to dephosphorylation of the Kir2.1 channel43,44. 
Thus, integrated bioelectric and secondary signaling mechanisms may have broader roles in development and 
physiology that previously expected.
Coordination of growth and proportion. Regulation of overgrowth by Kcnk5b/calcineurin signaling is 
coordinated among diverse tissues of the developing and regenerating fin to establish a larger, functional struc-
ture. This coordination may be attained through a re-interpretation of positional information within the fin such 
that regenerating tissues replace the missing components with tissue in register with the distal edge of the remain-
ing fin stump. Positional information within the fin may be set up and driven by differential gene expression 
patterns in development45,46. Rabinowitz et al.46 detail expression profiles of wild-type fins that support dynamic 
regulation of gene expression across the proximal-distal aspect of the fin. Interestingly, a significant class of genes 
differentially isolated in these studies was ion channels, suggesting that bioelectric signaling may be a key factor 
of this asymmetry and establishment of positional cues. The work on calcineurin by Kujawski et al.26 also would 
point to calcineurin signaling as mediating position and being able to re-specify identity when altered. This mech-
anism was founded on extended gene expression domains in the proximal component of the fin and delayed 
distal bifurcation of the rays after calcineurin inhibition. However, an alternate explanation for the observed 
changes in pattern is that the expanded proximal molecular and anatomical identities observed in FK506-treated 
fins are a consequence of increased growth rate, such that larger regional domains, interpreted as position, are 
generated rather than specific changes in identity per se. This hypothesis would explain observed overgrowth as 
well as extended branching of the fin, but would be independent of changes in positional memory. Alternatively, 
positional information is independent of size-instructive signals suggesting that modification of identity markers 
stemming from Kcnk5b/calcineurin signaling is coincident, but independent from, mechanisms of size determi-
nation and relative proportion.
Our data link the growth regulation of Kcnk5b and calcineurin and demonstrate that their function is not suf-
ficient to re-specify identity, rather to override it. Establishing, or re-establishing, identity in the fin may require 
signals present only during development and may not be malleable during regeneration. Long-term treatment of 
fish during development with FK506 leads to global alterations in growth of the body that make comparison of 
proportion difficult (Fig. S4). Thus, identification of these developmental cues to regulate proportion and size will 
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require dissociation by other means. Our findings suggest that the regulation of growth by Kcnk5b/calcineurin 
fulfills the general requirements of a scaling property previously defined by relative growth comparisons and 
represented by the rate constant of Huxley and Teissier (1939). The encoding and specification of absolute size, 
however remains undefined.
Methods
Fish Husbandry. The zebrafish AB strains and Tübingen (Tü) strains carrying albino mutation were used 
as background for all experiments. Fish were bred and maintained as previously described47. All experimental 
procedures involving fish conform to AAALAC standards and were approved by institutional IACUC commit-
tees. A complete description of the husbandry and environmental conditions in housing for the fish used in these 
experiments is available as a collection in protocols.io https://doi.org/10.17504/protocols.io.mrjc54n.
For all experiments, adult stages defined by reproductively mature fish >3 months old were used for analysis. 
Mutant alleles used in this work are alf dt30mh, sof dj7e2, and kcnk5b j131x8.
Fin Regeneration and Measurements. Fish were anesthetized by treatment with tricaine for meas-
urements and pectoral fin amputation. Unless otherwise indicated, pectoral fins of wildtype and mutants were 
resected to roughly 50% their pre-cut length using standard surgical scissors. Fin length was measured before, 
during and after regeneration using handheld calipers and measurements were normalized to the fish standard 
length, determined as the length from the tip of the snout to the posterior end of the caudal peduncle. Fin growth 
rate was measured for individual fish as the slope of the linear growth regression line over time from the ampu-
tation stump through the cessation of growth. Regeneration was considered complete for both treatment groups 
when the DMSO-treated control fins stopped growing (~3 weeks). ANOVA was used to compare mean fin growth 
of the genotypes and FK506 treatment groups. A genotype by treatment interaction test assessed whether the 
effect of FK506 was similar in all genotypes. Post-hoc pairwise comparisons between groups were adjusted for 
multiple comparisons using the Tukey-Kramer method. Analysis was done with SAS 9.4 (Cary, NC).
FK506 Treatment. Stock FK506 (Sigma) was dissolved in dimethyl sulfoxide (DMSO; Sigma). Fish water 
was treated with 100 nM FK506 unless otherwise indicated. Up to five individual zebrafish were housed in 1 L of 
FK506- or DMSO-treated fish water and were fed daily with live artemia. Water and drug were refreshed every 
other day throughout the duration of the experiment.
qRT-PCR. Five days post amputation, pectoral fin regenerates were collected from five individuals of each 
treatment group. For RNA extraction, tissue was homogenized in TRIzol Reagent (Invitrogen). cDNA syn-
thesis was performed with oligo dT primers using SuperScript III Reverse Transcription Kit (Invitrogen). 
qRT-PCR was performed with Power SYBR Green Master Mix (Applied Biosystems) on Applied Biosystems 
ViiA 7 Real Time PCR System. Cycling conditions: 10 minutes at 95 °C; 40 cycles of 15 seconds at 95 °C fol-
lowed by 1 minute at 60 °C; melting curve analysis with 15 seconds at 95 °C, 1 minute at 60 °C and 15 seconds 
at 95 °C. Temperature was varied at 1.6 °C/s. Expression levels were normalized relative to β-actin. ddCt was 
used to calculate fold change in FK506-treated relative to the average of DMSO-treated fish. Kcnk5b primers: 
5′-TTGTAGCCGTCTGTGACCAA-3′, 5′-AGTACCGCACCCAAACTGTC-3′. β-actin primers: 5′-CAACAACC 
TGCTGGGCAAA-3′, 5′-GCGTCGATGTCGAAGGTCA-3′.
Electrophysiology. The cDNA of Kcnk5b was subcloned into pSGEM for cRNA expression. The plasmid 
was linearized using NheI and cRNA was in vitro synthesized using the T7 mMessage mMachine kit (Ambion). 
Xenopus laevis oocytes were provided by Ecocyte Bioscience. Oocyte handling, injection and electrophysiological 
recordings were as previously described48. Briefly, stage V oocytes were injected with 4 ng of cRNA encoding 
wildtype or mutant I290A kcnk5b and stored for 3 days at 18 °C in Barth’s solution containing (in mmol/L): 88 
NaCl, 1.0 KCl, 2.4 NaHCO3, 0.33 Ca(NO3)2, 0.4 CaCl2, 0.8 MgSO4, 5 Tris-HCl, penicillin-G (63 mg/L), gen-
tamicin (100 mg/L), streptomycin sulfate (40 mg/L), theophylline (80 mg/L); pH 7.6. Two-electrode-voltage–
clamp recordings were performed at 22 °C using a Turbo Tec-10CD amplifier (NPI electronics), Digidata 
1322 A AD/DA-interface and pCLAMP 9.0 software (Axon Instruments Inc./Molecular Devices). Before 
measurement oocytes were pre-incubated in 0.5% DMSO (control) or in 50 µM FK506 (InvivoGen) for 1 h at 
18 °C in ND96 recording solution containing (in mM): 96 NaCl, 4 KCl, 1.8 MgCl2, 1.0 CaCl2, 5 HEPES; pH 
7.6. FK506 was dissolved in DMSO and FK506 dilution in ND96 was prepared freshly before every exper-
iment. Recording pipettes were filled with 3 M KCl and had resistances of 0.5–1.5 MΩ. Data were analyzed 
with Clampfit 9.0 (Molecular Devices Corporation), Excel (Microsoft) and Prism6 (GraphPad Software). 
p-values were corrected for multiple hypothesis testing using Bonferroni test in Origin software (OriginLab, 
Northampton, MA). The Kcnk5b I290A variant was generated by QuikChange II (Agilent). Mutagenesis primers: 
5′-CTCGCTCTGGAGTCGCTGACATCTTTGAG-3′, 5′-CTCAAAGATGTCAGCGACTCCAGAGCGAG-3′.
CRISPR generation of kcnk5b somatic clones. The fifth and terminal exon of zebrafish kcnk5b encodes 
the last transmembrane domain and cytoplasmic C-terminus. We designed guide RNAs (gRNA) tiling this exon 
to screen for sufficiency of deletions in this region to affect fin growth in mosaic injected animals. The ChopChop 
online was used to design gRNAs to limit predicted off-target gRNA cutting49,50. The pool of 5 distinct gRNAs 
were simultaneously injected to blanket the start of the exon. These gRNAs were assembled according to Gangon 
et al.51. Briefly, oligos containing the gRNA target were annealing to a universal oligo containing the tracrRNA 
and SP6 promoter. The annealed oligo ends were then filled in with T4 polymerase for 20 minutes at 12 °C. gRNA 
was synthesized from this oligo template using Ambion MEGAscript SP6 Kit. For transcription efficiency, the first 
two bases of each gRNA were changed to ‘GG’ as there is evidence that these bases have less effect on Cas9 cutting 
efficiency or off-target binding than mutations closer to the PAM site52–54. gRNAs were injected into single cell 
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zebrafish embryos at a concentration of 50 ng/μl blanket and 300 ng/μl Cas9. To screen for deletion efficiency, the 
target exon was amplified from pools of three 24 hour embryos and the resulting amplicons were heated to 95 °C 
and cooled at −0.1 °C per second to form heteroduplexes. Following heteroduplex PCR, a T7 endonuclease diges-
tion for 30 minutes at 37 °C in NEB Buffer 2 was used to generate deletions in the presence of Cas9-induced indels. 
Primers for colony PCR cloning of the exon 5 screen: 5′-GGCAAATCAAACTGGTTAGTCC-3′, 5′-CGCTGTAG 
TCCTCGACCTTC-3′. gRNA sequences: 5′-ATCACTTTGTTTCCATACAG-3′, 5′-GACAAAGAA 
TCTGTAGAGAG-3′, 5′-GGATCTACCTGGGCCTTGCT-3′, 5′-TTGGAACGTGCATATGGTGG-3′, 5′-CGTCAT 
GGTGGGCAGCCTG-3′.
Significance Statement. The diversity of forms in Nature is frequently derived from variation in the 
proportions of organs and tissues. The ability of organs and tissues to attain proper proportions is generally 
unknown. Recent work has shown that inhibition of the activity of calcineurin modulates size of fins in zebrafish. 
Here, we show that the action of a potassium channel, Kcnk5b is required for growth caused by calcineurin inhi-
bition. Importantly, we show that these factors specify fin growth independently from inherent cues of size and 
positional identity of the fin. Our work shows that this signaling node acts as a molecular rheostat, able to inte-
grate bioelectric and calcium-mediated signaling systems to dial relative growth rates guiding ultimate fin size.
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